Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals, 27131 [2019-12278]
Download as PDF
<![CDATA[
27131
Federal Register / Vol. 84, No. 112 / Tuesday, June 11, 2019 / Notices
0002. Send one self-addressed adhesive
label to assist that office in processing
your requests. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the draft guidance document.
Sau
L. Lee, Center for Drug Evaluation and
Research, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 22, Rm. 2130, Silver Spring,
MD 20993–0002, 301–796–2905.
FOR FURTHER INFORMATION CONTACT:
SUMMARY:
Persons with access to the internet
may obtain the draft guidance at either
https://www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs or https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Dated: June 6, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–12292 Filed 6–10–19; 8:45 am]
BILLING CODE 4164–01–P
SUPPLEMENTARY INFORMATION:
The Food and Drug
Administration (FDA) is publishing a
list of information collections that have
been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
II. Electronic Access
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
The
following is a list of FDA information
collections recently approved by OMB
under section 3507 of the Paperwork
Reduction Act of 1995 (44 U.S.C. 3507).
The OMB control number and
expiration date of OMB approval for
each information collection are shown
in table 1. Copies of the supporting
statements for the information
collections are available on the internet
at https://www.reginfo.gov/public/do/
PRAMain. An Agency may not conduct
or sponsor, and a person is not required
to respond to, a collection of
information unless it displays a
currently valid OMB control number.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of February
27, 2019, FDA published a notice with
a 90-day comment period to request
comments on the draft guidance for
industry entitled ‘‘Quality
Considerations for Continuous
Manufacturing.’’ FDA is reopening the
comment period until August 12, 2019.
The Agency believes that an additional
60 days will allow adequate time for
interested persons to submit comments
without compromising the timely
publication of the final version of the
guidance.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA–2018–N–0215; FDA–
2012–N–0248; FDA–2015–N–2126; FDA–
2012–N–0280; FDA–2012–N–1093; FDA–
2018–N–4130; and FDA–2011–N–0143]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approvals
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB control
No.
Title of collection
Healthcare Professional Survey of Professional Prescription Drug Promotion ......................................................
Formal Dispute Resolutions; Appeals Above the Division Level ............................................................................
Food and Drug Administration’s Research and Evaluation Survey for the Public Education Campaign on Tobacco Among LGBT (RESPECT) ........................................................................................................................
Financial Disclosure by Clinical Investigators .........................................................................................................
Food Additive Petitions and Investigational Food Additive Exemptions .................................................................
Recordkeeping Requirements for Microbiological Testing and Corrective Measures for Bottled Water ...............
Foreign Supplier Verification Programs for Importers of Food for Humans and Animals ......................................
Dated: June 6, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–12278 Filed 6–10–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
khammond on DSKBBV9HB2PROD with NOTICES
17:36 Jun 10, 2019
Jkt 247001
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
ADDRESSES:
Food and Drug Administration,
VerDate Sep<11>2014
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing that a proposed
collection of information has been
submitted to the Office of Management
and Budget (OMB) for review and
clearance under the Paperwork
Reduction Act of 1995.
SUMMARY:
Fax written comments on the
collection of information by July 11,
2019.
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Mitigation
Strategies To Protect Food Against
Intentional Adulteration
HHS.
Notice.
DATES:
[Docket No. FDA–2013–N–1425]
AGENCY:
ACTION:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Date approval
expires
0910–0869
0910–0430
4/30/2020
3/31/2022
0910–0808
0910–0396
0910–0546
0910–0658
0910–0752
3/31/2022
4/30/2022
4/30/2022
4/30/2022
4/30/2022
comments should be identified with the
OMB control number 0910–0812. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Domini Bean, Office of Operations,
Food and Drug Administration, Three
White Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–5733, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 84, Number 112 (Tuesday, June 11, 2019)]
[Notices]
[Page 27131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-12278]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2018-N-0215; FDA-2012-N-0248; FDA-2015-N-2126; FDA-
2012-N-0280; FDA-2012-N-1093; FDA-2018-N-4130; and FDA-2011-N-0143]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Healthcare Professional Survey of 0910-0869 4/30/2020
Professional Prescription Drug
Promotion..............................
Formal Dispute Resolutions; Appeals 0910-0430 3/31/2022
Above the Division Level...............
Food and Drug Administration's Research 0910-0808 3/31/2022
and Evaluation Survey for the Public
Education Campaign on Tobacco Among
LGBT (RESPECT).........................
Financial Disclosure by Clinical 0910-0396 4/30/2022
Investigators..........................
Food Additive Petitions and 0910-0546 4/30/2022
Investigational Food Additive
Exemptions.............................
Recordkeeping Requirements for 0910-0658 4/30/2022
Microbiological Testing and Corrective
Measures for Bottled Water.............
Foreign Supplier Verification Programs 0910-0752 4/30/2022
for Importers of Food for Humans and
Animals................................
------------------------------------------------------------------------
Dated: June 6, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-12278 Filed 6-10-19; 8:45 am]
BILLING CODE 4164-01-P
